Request Demo
Recent blog posts
Latest Hotspot
8 min read
NCT07796126 Albumin-Bound Paclitaxel Squamous Cell Carcinoma of Head and Neck Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07796126 clinical trial report covering Albumin-Bound Paclitaxel, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07795814 EDG-15400 Heart failure with normal ejection fraction Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07795814 clinical trial report covering EDG-15400, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07794488 Recombinant Human Endostatin (Simcere) Nasopharyngeal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07794488 clinical trial report covering Recombinant Human Endostatin (Simcere), Phase 2, endpoints, sponsor, geography, readout timing and development w
Latest Hotspot
8 min read
NCT07795424 Trastuzumab Hormone receptor positive HER2 positive breast cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07795424 clinical trial report covering Trastuzumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07793942 Epinephrine Bitartrate Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07793942 clinical trial report covering Epinephrine Bitartrate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07770984 Ombitasvir/Paritaprevir/Ritonavir Hepatitis C Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07770984 clinical trial report covering Ombitasvir/Paritaprevir/Ritonavir, Phase 2/3, endpoints, sponsor, geography, readout timing and development whit
Latest Hotspot
8 min read
NCT07795177 Rezvilutamide Hormone-dependent prostate cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07795177 clinical trial report covering Rezvilutamide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07795125 Rimegepant Sulfate Endometriosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07795125 clinical trial report covering Rimegepant Sulfate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07784816 Girocitinib Dermatitis, Atopic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07784816 clinical trial report covering Girocitinib, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07786922 Avatrombopag Maleate Sveinsson Chorioretinal Atrophy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07786922 clinical trial report covering Avatrombopag Maleate, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07767188 Obinutuzumab Lupus Nephritis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07767188 clinical trial report covering Obinutuzumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07792681 BR005-036C Migraine Disorders Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
1 September 2026
NCT07792681 clinical trial report covering BR005-036C, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.